ArticleCardiovascular research2021

Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart.

Yu Jin Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.